Fisher & Paykel Healthcare Corporation Ltd (FPH) - Net Assets

Latest as of September 2025: AU$1.97 Billion AUD

Based on the latest financial reports, Fisher & Paykel Healthcare Corporation Ltd (FPH) has net assets worth AU$1.97 Billion AUD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$2.61 Billion) and total liabilities (AU$639.89 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$1.97 Billion
% of Total Assets 75.48%
Annual Growth Rate 9.59%
5-Year Change 35.17%
10-Year Change 286.67%
Growth Volatility 13.63

Fisher & Paykel Healthcare Corporation Ltd - Net Assets Trend (2000–2025)

This chart illustrates how Fisher & Paykel Healthcare Corporation Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Fisher & Paykel Healthcare Corporation Ltd (2000–2025)

The table below shows the annual net assets of Fisher & Paykel Healthcare Corporation Ltd from 2000 to 2025.

Year Net Assets Change
2025-03-31 AU$1.89 Billion +7.46%
2024-03-31 AU$1.76 Billion +7.19%
2023-03-31 AU$1.64 Billion +5.48%
2022-03-31 AU$1.56 Billion +11.25%
2021-03-31 AU$1.40 Billion +48.26%
2020-03-31 AU$943.25 Million +7.58%
2019-03-31 AU$876.75 Million +22.44%
2018-03-31 AU$716.08 Million +18.11%
2017-03-31 AU$606.29 Million +24.01%
2016-03-31 AU$488.89 Million +3.76%
2015-03-31 AU$471.19 Million +16.02%
2014-03-31 AU$406.12 Million +9.10%
2013-03-31 AU$372.23 Million +6.92%
2012-03-31 AU$348.15 Million +11.13%
2011-03-31 AU$313.29 Million +6.87%
2010-03-31 AU$293.16 Million +43.50%
2009-03-31 AU$204.30 Million +4.41%
2008-03-31 AU$195.66 Million +1.11%
2007-03-31 AU$193.51 Million -5.14%
2006-03-31 AU$203.99 Million +6.23%
2005-03-31 AU$192.03 Million +0.42%
2004-03-31 AU$191.22 Million -0.83%
2003-03-31 AU$192.82 Million +12.18%
2002-03-31 AU$171.88 Million +13.01%
2001-03-31 AU$152.09 Million -20.55%
2000-03-31 AU$191.42 Million --

Equity Component Analysis

This analysis shows how different components contribute to Fisher & Paykel Healthcare Corporation Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 122660000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2025)

Component Amount Percentage
Retained Earnings AU$1.23 Billion 64.89%
Common Stock AU$468.60 Million 24.79%
Other Comprehensive Income AU$195.20 Million 10.33%
Total Equity AU$1.89 Billion 100.00%

Fisher & Paykel Healthcare Corporation Ltd Competitors by Market Cap

The table below lists competitors of Fisher & Paykel Healthcare Corporation Ltd ranked by their market capitalization.

Company Market Cap
Sterling Construction Company Inc
NASDAQ:STRL
 		$12.99 Billion
Impala Platinum Holdings Ltd
JSE:IMP
 		$13.02 Billion
Neurocrine Biosciences Inc
NASDAQ:NBIX
 		$13.03 Billion
Penumbra Inc
NYSE:PEN
 		$13.03 Billion
Gaming & Leisure Properties
NASDAQ:GLPI
 		$12.97 Billion
LIG Nex1 Co Ltd
KO:079550
 		$12.97 Billion
Samsung Fire & Marine Insurance
KO:000810
 		$12.96 Billion
HDFC Asset Management Company Limited
NSE:HDFCAMC
 		$12.93 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Fisher & Paykel Healthcare Corporation Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 1,759,100,000 to 1,890,400,000, a change of 131,300,000 (7.5%).
  • Net income of 377,200,000 contributed positively to equity growth.
  • Dividend payments of 195,900,000 reduced retained earnings.
  • New share issuances of 3,100,000 increased equity.
  • Other comprehensive income decreased equity by 64,900,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$377.20 Million +19.95%
Dividends Paid AU$195.90 Million -10.36%
Share Issuances AU$3.10 Million +0.16%
Other Comprehensive Income AU$-64.90 Million -3.43%
Other Changes AU$11.80 Million +0.62%
Total Change AU$- 7.46%

Book Value vs Market Value Analysis

This analysis compares Fisher & Paykel Healthcare Corporation Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 9.75x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 105.00x to 9.75x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2001-03-31 AU$0.30 AU$31.23 x
2002-03-31 AU$0.31 AU$31.23 x
2003-03-31 AU$0.37 AU$31.23 x
2004-03-31 AU$0.36 AU$31.23 x
2005-03-31 AU$0.37 AU$31.23 x
2006-03-31 AU$0.39 AU$31.23 x
2007-03-31 AU$0.37 AU$31.23 x
2008-03-31 AU$0.37 AU$31.23 x
2009-03-31 AU$0.39 AU$31.23 x
2010-03-31 AU$0.55 AU$31.23 x
2011-03-31 AU$0.59 AU$31.23 x
2012-03-31 AU$0.64 AU$31.23 x
2013-03-31 AU$0.67 AU$31.23 x
2014-03-31 AU$0.73 AU$31.23 x
2015-03-31 AU$0.83 AU$31.23 x
2016-03-31 AU$0.85 AU$31.23 x
2017-03-31 AU$1.06 AU$31.23 x
2018-03-31 AU$1.24 AU$31.23 x
2019-03-31 AU$1.52 AU$31.23 x
2020-03-31 AU$1.63 AU$31.23 x
2021-03-31 AU$2.42 AU$31.23 x
2022-03-31 AU$2.68 AU$31.23 x
2023-03-31 AU$2.82 AU$31.23 x
2024-03-31 AU$3.00 AU$31.23 x
2025-03-31 AU$3.20 AU$31.23 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Fisher & Paykel Healthcare Corporation Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 19.95%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 29.46%
  • • Asset Turnover: 0.50x
  • • Equity Multiplier: 1.35x
  • Recent ROE (19.95%) is below the historical average (24.26%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2000 14.69% 6.64% 0.92x 2.40x AU$8.97 Million
2001 6.38% 5.03% 0.81x 1.56x AU$-5.50 Million
2002 28.00% 22.57% 0.99x 1.25x AU$30.94 Million
2003 37.81% 34.98% 0.91x 1.19x AU$53.62 Million
2004 28.60% 25.46% 0.96x 1.17x AU$35.58 Million
2005 31.98% 25.46% 1.05x 1.20x AU$42.20 Million
2006 34.30% 24.16% 1.08x 1.31x AU$49.57 Million
2007 29.77% 16.49% 1.27x 1.42x AU$38.25 Million
2008 18.03% 10.20% 1.04x 1.70x AU$15.71 Million
2009 30.46% 12.82% 1.17x 2.03x AU$41.80 Million
2010 24.43% 15.09% 1.00x 1.62x AU$42.31 Million
2011 16.75% 11.22% 0.90x 1.65x AU$21.14 Million
2012 18.41% 13.74% 0.82x 1.64x AU$29.29 Million
2013 20.70% 15.19% 0.82x 1.66x AU$39.83 Million
2014 23.90% 17.07% 0.90x 1.55x AU$56.44 Million
2015 24.02% 17.57% 0.96x 1.42x AU$66.05 Million
2016 29.34% 19.41% 1.07x 1.42x AU$94.54 Million
2017 27.90% 21.23% 0.99x 1.33x AU$108.52 Million
2018 26.56% 20.97% 0.94x 1.35x AU$118.59 Million
2019 23.86% 20.32% 0.89x 1.32x AU$121.52 Million
2020 30.46% 23.29% 0.89x 1.47x AU$192.98 Million
2021 37.48% 26.59% 1.03x 1.36x AU$384.35 Million
2022 24.22% 22.41% 0.86x 1.25x AU$221.31 Million
2023 15.25% 15.76% 0.77x 1.26x AU$86.19 Million
2024 7.54% 7.61% 0.76x 1.30x AU$-43.31 Million
2025 19.95% 29.46% 0.50x 1.35x AU$188.16 Million

Industry Comparison

This section compares Fisher & Paykel Healthcare Corporation Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $99,308,122
  • Average return on equity (ROE) among peers: -25.52%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Fisher & Paykel Healthcare Corporation Ltd (FPH) AU$1.97 Billion 14.69% 0.32x $12.98 Billion
Austco Healthcare Ltd (AHC) $6.75 Million -163.73% 0.87x $91.48 Million
Ansell Ltd (ANN) $537.47 Million -0.46% 2.39x $2.77 Billion
Nanosonics Ltd (NAN) $-741.00K 0.00% 0.00x $759.81 Million
Osteopore Ltd (OSX) $4.23 Million -20.56% 0.28x $2.05 Million
SDI Ltd (SDI) $30.40 Million 16.84% 0.71x $104.29 Million
Trajan Group Holdings Ltd (TRJ) $17.74 Million 14.77% 1.50x $42.09 Million

About Fisher & Paykel Healthcare Corporation Ltd

AU:FPH Australia Medical Instruments & Supplies
Market Cap
$12.98 Billion
AU$18.34 Billion AUD
Market Cap Rank
#1660 Global
#29 in Australia
Share Price
AU$31.23
Change (1 day)
-1.26%
52-Week Range
AU$30.00 - AU$34.84
All Time High
AU$35.66
Categories
Companies in Australia Medical Instruments & Supplies
About

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The com… Read more